<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 19.3: N-of-1 Trials and Practice-Based Evidence</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Research & Evidence */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e3a8a;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #DBEAFE 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #1e40af;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
            background: #f0f9ff;
            padding: 2px 6px;
            border-radius: 4px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
            line-height: 1.6;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border: 1px solid #cbd5e1;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
            border-bottom: 1px solid #eee;
            padding-bottom: 10px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: L2: Research & Evidence</p>
            <h1 class="lesson-title">Lesson 19.3: N-of-1 Trials and Practice-Based Evidence</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Epistemology of the Individual</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Designing N-of-1 Trials</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Statistical Methods: C-Statistic</a></li>
                <li><a href="#section4"><span class="section-num">4</span>PROMs and PREMs</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Washout Challenge</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Practice-Based Research Networks</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Design scientifically rigorous N-of-1 trials to validate the 'Individualized Care' (I) pillar of the B.R.I.D.G.E. Methodâ„¢.</li>
                <li>Apply visual analysis and the C-statistic to interpret single-subject clinical data.</li>
                <li>Select appropriate Patient-Reported Outcome Measures (PROMs) for chronic symptom tracking.</li>
                <li>Calculate and implement effective washout periods to prevent carryover effects in cross-over designs.</li>
                <li>Understand the ethical framework for contributing de-identified client data to Practice-Based Research Networks (PBRNs).</li>
            </ul>
        </div>

        <h2 id="section1">1. The Epistemology of the Individual</h2>
        <p>In previous lessons, we discussed the hierarchy of evidence and the gold standard of the Randomized Controlled Trial (RCT). However, for the Integrative Medicine Practitioner, the RCT presents a fundamental paradox: <span class="highlight">it is designed to find the "average" response for an "average" person</span>, a person who rarely exists in the clinical setting. This is where the <span class="term">N-of-1 trial</span> (or single-subject design) becomes the bridge between rigorous science and bio-individual care.</p>

        <p>An N-of-1 trial is a multi-period crossover trial conducted in a single individual. While traditional research asks, "Does this intervention work for the population?", the N-of-1 trial asks, "Does this intervention work for <em>this</em> specific client, with their unique genetic SNPs, microbiome composition, and environmental exposures?"</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Randomized Controlled Trial (RCT)</th>
                        <th>N-of-1 Trial (Single Subject)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Goal</strong></td>
                        <td>Generalizability to a population.</td>
                        <td>Optimizing care for the individual.</td>
                    </tr>
                    <tr>
                        <td><strong>Population</strong></td>
                        <td>Large (n=100s to 1000s).</td>
                        <td>n=1.</td>
                    </tr>
                    <tr>
                        <td><strong>Statistical Focus</strong></td>
                        <td>Mean differences between groups.</td>
                        <td>Variation within the individual over time.</td>
                    </tr>
                    <tr>
                        <td><strong>Clinical Utility</strong></td>
                        <td>Informs guidelines and policy.</td>
                        <td>Informs immediate clinical decision-making.</td>
                    </tr>
                    <tr>
                        <td><strong>Heterogeneity</strong></td>
                        <td>Viewed as "noise" to be controlled.</td>
                        <td>Viewed as the primary focus of study.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section2">2. Designing Scientifically Rigorous N-of-1 Trials</h2>
        <p>To move beyond simple "trial and error," an N-of-1 trial must adhere to specific design principles to ensure the data is actionable. Within the <span class="highlight">B.R.I.D.G.E. Methodâ„¢</span>, this falls under the "D" (Data-Driven Decisions) and "I" (Individualize Care) pillars.</p>

        <h3>The A-B-A-B Design</h3>
        <p>The most common rigorous design is the <span class="term">Reversal Design (A-B-A-B)</span>. In this model:</p>
        <ul>
            <li><strong>Phase A (Baseline/Placebo):</strong> The client tracks symptoms without the intervention (or with a placebo).</li>
            <li><strong>Phase B (Intervention):</strong> The client introduces the supplement, diet, or lifestyle change.</li>
            <li><strong>Phase A (Withdrawal):</strong> The intervention is removed to see if symptoms return.</li>
            <li><strong>Phase B (Re-introduction):</strong> The intervention is added back to confirm the effect.</li>
        </ul>

        <p><span class="stat-highlight">A 2020 systematic review of N-of-1 trials (n=108 studies)</span> found that this methodology led to a change in treatment management in 54% of cases and increased client confidence in their treatment plan by over 70%. For the practitioner, this eliminates the "supplement graveyard" where clients take 20 pills without knowing which ones are actually providing value.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: Validating Mitochondrial Support</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James D., 44</h4>
                        <p>Presenting with chronic fatigue, brain fog, and post-exertional malaise. High oxidative stress markers on organic acids testing.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Coenzyme Q10 (Ubiquinol) at 400mg/day. James was skeptical of supplement costs.</p>
                <p><strong>Design:</strong> A-B-A-B trial over 8 weeks (2 weeks per phase). James used a 1-10 VAS scale for "Mental Clarity" and "Energy Levels" daily.</p>
                <p><strong>Outcome:</strong> Visual analysis showed a clear "step-up" in energy scores from a mean of 3.2 (Phase A1) to 6.8 (Phase B1). When Ubiquinol was withdrawn (Phase A2), scores dropped to 4.1 within 4 days. Re-introduction (Phase B2) restored scores to 7.1. This provided James with the "Practice-Based Evidence" needed to commit to long-term mitochondrial support.</p>
            </div>
        </div>

        <h2 id="section3">3. Statistical Methods: Visual Analysis and C-Statistic</h2>
        <p>Because N-of-1 trials don't use P-values in the traditional sense, we rely on <span class="term">Time-Series Analysis</span>. The two primary methods for the practitioner are Visual Inspection and the C-statistic.</p>

        <h3>Visual Analysis</h3>
        <p>This involves plotting data on a line graph. Practitioners look for:</p>
        <ul>
            <li><strong>Level:</strong> The average score in each phase.</li>
            <li><strong>Trend:</strong> The slope of the data (is it improving or worsening over the 14 days?).</li>
            <li><strong>Latency:</strong> How quickly the change occurs after the intervention starts.</li>
        </ul>

        <h3>The C-Statistic (Trend Analysis)</h3>
        <p>The <span class="term">C-statistic</span> is a simplified statistical tool used to detect trends in small datasets. It calculates whether the sequence of data points is random or follows a significant pattern. A C-value greater than <span class="stat-highlight">1.64 (p < 0.05)</span> suggests a non-random trend, providing mathematical weight to the observation that the intervention is truly responsible for the change.</p>

        <h2 id="section4">4. Utilizing PROMs and PREMs for Data Collection</h2>
        <p>To make N-of-1 trials work, we need standardized ways to measure how the client feels. We categorize these into two groups:</p>

        <h3>Patient-Reported Outcome Measures (PROMs)</h3>
        <p>PROMs measure the <em>functional status</em> or <em>symptom burden</em>. Examples include:</p>
        <ul>
            <li><strong>MSQ (Medical Symptom Questionnaire):</strong> Tracks total body toxic load across systems.</li>
            <li><strong>PHQ-9 or GAD-7:</strong> Standardized scales for mood and anxiety.</li>
            <li><strong>VAS (Visual Analogue Scale):</strong> A simple 0-10 line for specific symptoms like "Bloating" or "Joint Pain."</li>
        </ul>

        <h3>Patient-Reported Experience Measures (PREMs)</h3>
        <p>PREMs measure the <em>process</em> of care. Did the client find the intervention easy to follow? Did they feel heard? In the <span class="highlight">BRIDGE Methodâ„¢</span>, PREMs are essential during the "G" (Guide the Journey) phase to ensure long-term compliance. If a protocol is effective (high PROM score) but unsustainable (low PREM score), it will eventually fail.</p>

        <h2 id="section5">5. Overcoming the 'Washout Period' Challenge</h2>
        <p>The greatest threat to N-of-1 validity is the <span class="term">Carryover Effect</span>. If a client stops taking a fat-soluble nutrient like Vitamin D or a botanical with a long half-life, the effects may linger into the "Withdrawal" (Phase A2) period, masking the results.</p>

        <p><strong>Calculating the Washout:</strong> As a rule of thumb, a washout period should be at least <span class="highlight">5 times the half-life</span> of the substance. For most water-soluble supplements (B-vitamins, Vitamin C), 3-5 days is sufficient. However, for interventions affecting the microbiome or gene expression (epigenetic modulators), a washout of 2-4 weeks may be required to reach a true baseline.</p>

        <div class="alert-box warning">
            <p class="alert-label">Clinical Pearl: The "Order Effect"</p>
            <p>Always consider the "Order Effect"â€”the possibility that the sequence of interventions matters. If testing two different probiotics, the first one may permanently alter the terrain, making the second one appear more (or less) effective than it would have been in isolation.</p>
        </div>

        <h2 id="section6">6. Practice-Based Research Networks (PBRNs)</h2>
        <p>While N-of-1 trials are powerful for the individual, <span class="term">Practice-Based Evidence (PBE)</span> aggregates these individual successes into larger datasets. A PBRN is a group of practitioners who collaborate to track outcomes across their collective client bases.</p>

        <p>By using the same "Root Cause Analysis" (R) and "Functional Matrix" (Module 2), a group of 50 practitioners can generate data on 500 clients with Hashimoto's, providing real-world evidence that might take a decade to fund through a traditional university RCT. <span class="stat-highlight">A 2021 report from the Integrative Health Policy Consortium</span> noted that PBRNs are currently the fastest-growing source of data for "non-pharmacological" interventions in chronic disease.</p>

        <h3>Ethics and Data Privacy</h3>
        <p>When participating in PBRNs or sharing case studies, practitioners must adhere to strict ethical guidelines:</p>
        <ol>
            <li><strong>Informed Consent:</strong> Clients must sign a release specifically allowing their de-identified data to be used for research purposes.</li>
            <li><strong>De-identification:</strong> Removing all "Protected Health Information" (PHI) including names, exact birthdates, and addresses.</li>
            <li><strong>The "Clinician-Researcher" Dual Role:</strong> Ensure that the pursuit of data never compromises the primary duty of care to the client.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of N-of-1 trial design and analysis.</p>

            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">In an A-B-A-B trial, what is the primary purpose of the second "A" phase (the withdrawal phase)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The second "A" phase serves to confirm that the improvement seen in the first "B" phase was actually due to the intervention and not just a coincidence, placebo effect, or natural resolution of the symptom. If the symptom returns when the intervention is removed, it strengthens the evidence of causality.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">A practitioner is testing a new herbal antimicrobial for SIBO. Why might a 3-day washout period be insufficient for an N-of-1 crossover design?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Antimicrobials change the microbial ecosystem (the "terrain"). These changes are not immediately reversed when the herb is stopped. A 3-day period is likely too short to allow the microbiome to return to its pre-intervention baseline, leading to a "carryover effect" that would muddy the data of the next phase.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>N-of-1 trials are the ultimate tool for validating <span class="highlight">Bio-Individuality</span> within a scientific framework.</li>
                <li>Rigorous design (A-B-A-B) and statistical tools (C-statistic) elevate clinical observation to practice-based evidence.</li>
                <li>Washout periods are critical to prevent carryover effects; aim for 5x the half-life of the substance.</li>
                <li>PROMs track functional outcomes, while PREMs track the client's experience and adherence potential.</li>
                <li>Practice-Based Research Networks (PBRNs) allow integrative practitioners to contribute to the global evidence base while maintaining clinical focus.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Guyatt, G. et al. (1986). "Determining Optimal Therapy: Randomized Trials in Individual Patients." <i>New England Journal of Medicine</i>.</li>
                <li>Lillie, E. O. et al. (2011). "The Role of N-of-1 Trials in Personalized Medicine." <i>Personalized Medicine</i>.</li>
                <li>Margolis, S. A. et al. (2020). "Practice-Based Research Networks: The Future of Integrative Medicine Research." <i>Journal of Alternative and Complementary Medicine</i>.</li>
                <li>Schork, N. J. (2015). "Personalized Medicine: Time for One-Person Trials." <i>Nature</i>.</li>
                <li>Kravitz, R. L. et al. (2014). "Design and Implementation of N-of-1 Trials: A Report from the Agency for Healthcare Research and Quality." <i>AHRQ Methods Reports</i>.</li>
                <li>Gabler, N. B. et al. (2011). "N-of-1 Trials in the Medical Literature: A Systematic Review." <i>Medical Care</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Proprietary B.R.I.D.G.E. Methodâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>